Cardinal Health, Inc. (NYSE:CAH) Shares Purchased by Natixis Advisors LLC

Natixis Advisors LLC raised its holdings in Cardinal Health, Inc. (NYSE:CAH) by 10.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 507,378 shares of the company’s stock after acquiring an additional 45,929 shares during the period. Natixis Advisors LLC owned approximately 0.21% of Cardinal Health worth $60,008,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Frazier Financial Advisors LLC raised its holdings in Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after acquiring an additional 104 shares during the last quarter. Promus Capital LLC acquired a new stake in Cardinal Health in the 4th quarter valued at about $30,000. AM Squared Ltd acquired a new stake in Cardinal Health in the 3rd quarter valued at about $33,000. Kentucky Trust Co acquired a new stake in Cardinal Health in the 4th quarter valued at about $41,000. Finally, HHM Wealth Advisors LLC raised its holdings in Cardinal Health by 57.6% in the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock valued at $47,000 after acquiring an additional 144 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

CAH has been the subject of a number of recent research reports. TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Citigroup raised their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday, January 10th. Argus set a $148.00 price target on shares of Cardinal Health in a report on Tuesday, February 4th. Mizuho began coverage on shares of Cardinal Health in a report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price target for the company. Finally, Morgan Stanley raised their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a report on Friday, January 31st. Four equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $139.36.

Cardinal Health Stock Up 1.5 %

Shares of CAH stock opened at $128.20 on Friday. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84. The stock has a market capitalization of $30.97 billion, a PE ratio of 23.92, a P/E/G ratio of 1.49 and a beta of 0.66. The firm has a 50 day moving average of $126.33 and a two-hundred day moving average of $119.38.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.58%. Cardinal Health’s dividend payout ratio (DPR) is currently 37.69%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.